BioMarin Pharmaceutical Inc. buy Robert W. Baird
Start price
30.01.24
/
50%
€82.64
Target price
30.01.25
€95.95
Performance (%)
-25.00%
End price
31.01.25
€61.98
Summary
This prediction ended on 31.01.25 with a price of €61.98. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.00%. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.129% | -0.129% | -10.727% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Robert_W__Baird for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Robert W. Baird from $127.00 to $104.00. They now have an "outperform" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Robert_W__Baird for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.16
13.07.23
13.07.23
€113.58
13.07.24
13.07.24
3.31%
14.07.24
14.07.24
